New York based securities law firm, Sichenzia Ross Friedman Ference LLP, acted as counsel to New York-based Synergy Pharmaceuticals Inc., a biopharmaceutical company focused primarily on the …
Sichenzia Ross Friedman Ference LLP client, Synergy Pharmaceuticals, Rings Nasdaq Closing Bell.
Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp on $5.8 million Secondary Public Offering for Netsol Technologies, Inc.
NEW YORK, March 8, 2012 (GLOBE NEWSWIRE) -- New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Aegis Capital Corp as sole underwriter in a $5.8 …
Sichenzia Ross Friedman Ference LLP Recognized as Number One PIPE Issuer Law Firm for 2011
Firm Has Been the Nation’s Leader in PIPEs Transactions Since 2004 New York, NY (January 18, 2012) – Sichenzia Ross Friedman Ference LLP (SRFF) has again earned the title of leading PIPE issuer law …
Sichenzia Ross Friedman Ference LLP Advises Fordham Financial on $9.4 million Registered Direct Offering for Ampio Pharmaceuticals.
NEW YORK, December 27, 2011 -- New York-based securities law firm, Sichenzia Ross Friedman Ference LLP, announced that it has represented Fordham Financial Management, Inc., as lead placement Agent in …
Sichenzia Ross Friedman Ference LLP Recognized as America’s Number One PIPE Issuer Law Firm for 2010
Firm Has Been the Nation’s Leader in PIPEs Transactions Since 2004 New York, NY (February 3, 2011) – Sichenzia Ross Friedman Ference LLP (SRFF) has again earned the title of leading PIPE issuer law …
